10.1093/sleep/zsae280 [DOI] [PubMed] [Google Scholar] 32.Yang L, Zhang M, Wu S, Zhou L, Li Y, Liu D (2025) The effect of GLP-1 receptor agonists on obstructive sleep apnea in patients with obesity or diabetes: a systematic review and meta-analysis
9 In the United States, the Department of Defenses Operation Supplement Safety and the FDA have flagged BPC-157 as an unapproved drug with unresolved concerns about impurities and immunogenicity when sold in injectable research products, and it has been the subject of ongoing compounding-eligibility review rather than approval
Wegovy (semaglutide): Also manufactured by Novo Nordisk, Wegovy contains the same active ingredient as Ozempic but at a higher dose and with FDA approval specifically for chronic weight management
Patients often experience steroid-like side effects (fluid retention, high blood sugar, mood changes, etc.)